PROQR THERAPEUTICS N (PRQR) insider trading activity (SEC Form 4). Over the trailing 90 days, PRQR insiders filed 5 purchases totalling $1.3M and 0 sales totalling $0 — net BUYING of $1.3M. Most recent filing: Aug 3, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | De Boer Daniel Anton | CEO | P Purchase | — | $1.77 | $354K | filing |
| Jul 21, 2026 | Filius Bart | Dir | P Purchase | — | $1.72 | $258K | filing |
| Jul 13, 2026 | De Boer Daniel Anton | CEO | P Purchase | — | $1.74 | $261K | filing |
| Jul 8, 2026 | De Boer Daniel Anton | CEO | P Purchase | — | $1.59 | $239K | filing |
| Jun 30, 2026 | Filius Bart | Dir | P Purchase | — | $1.54 | $231K | filing |